biospecimen_aliquot__bcr_aliquot_barcode	tcga-ew-a1iz-01a-11d-a188-09
biospecimen_aliquot__bcr_aliquot_uuid	18db4143-48cc-424c-8d23-46cf23056528
biospecimen_aliquot__bcr_patient_uuid	c0f88fc5-56b0-4255-bbd1-9a21ced8b37b
biospecimen_aliquot__bcr_sample_barcode	tcga-ew-a1iz-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0113421081
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.08
biospecimen_aliquot__date_of_shipment	2011-09-14
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	1
biospecimen_aliquot__plate_id	a188
biospecimen_aliquot__plate_row	f
biospecimen_aliquot__quantity	4.16
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	52.00
biospecimen_analyte__a260_a280_ratio	1.93
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-ew-a1iz-01a-11d
biospecimen_analyte__bcr_analyte_uuid	de23cee8-8510-4787-a7c8-b08ba99e8d69
biospecimen_analyte__bcr_patient_uuid	c0f88fc5-56b0-4255-bbd1-9a21ced8b37b
biospecimen_analyte__bcr_sample_barcode	tcga-ew-a1iz-01a
biospecimen_analyte__concentration	0.16
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	uv spec
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-ew-a1iz
biospecimen_diagnostic_slides__bcr_patient_uuid	c0f88fc5-56b0-4255-bbd1-9a21ced8b37b
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-ew-a1iz-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	81d5544e-0a7d-4a92-a3b0-4f22cfb8bbb2
biospecimen_normal_control__bcr_patient_barcode	tcga-ew-a1iz
biospecimen_normal_control__bcr_patient_uuid	c0f88fc5-56b0-4255-bbd1-9a21ced8b37b
biospecimen_portion__bcr_patient_uuid	c0f88fc5-56b0-4255-bbd1-9a21ced8b37b
biospecimen_portion__bcr_portion_barcode	tcga-ew-a1iz-01a-11
biospecimen_portion__bcr_portion_uuid	ac74f652-b6ab-4ea5-bec3-3619be3a302f
biospecimen_portion__bcr_sample_barcode	tcga-ew-a1iz-01a
biospecimen_portion__date_of_creation	2011-02-21
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	11
biospecimen_portion__portion_sequence	1
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-ew-a1iz-01a-11d
biospecimen_protocol__bcr_patient_uuid	c0f88fc5-56b0-4255-bbd1-9a21ced8b37b
biospecimen_protocol__bcr_sample_barcode	tcga-ew-a1iz-01a
biospecimen_protocol__experimental_protocol_type	adna preparation type
biospecimen_sample__bcr_patient_uuid	c0f88fc5-56b0-4255-bbd1-9a21ced8b37b
biospecimen_sample__bcr_sample_barcode	tcga-ew-a1iz-01a
biospecimen_sample__bcr_sample_uuid	ca459603-f477-4ff4-9d47-902b3cbad196
biospecimen_sample__days_to_collection	194
biospecimen_sample__initial_weight	130
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	true
biospecimen_sample__pathology_report_file_name	tcga-ew-a1iz.f5ef4698-364c-4a5b-a8ec-1cf231beef31.pdf
biospecimen_sample__pathology_report_uuid	f5ef4698-364c-4a5b-a8ec-1cf231beef31
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_shipment_portion__bcr_patient_uuid	c0f88fc5-56b0-4255-bbd1-9a21ced8b37b
biospecimen_shipment_portion__bcr_sample_barcode	tcga-ew-a1iz-01a
biospecimen_shipment_portion__bcr_shipment_portion_uuid	401f0a1d-c38e-463b-8195-8eba9ea21869
biospecimen_shipment_portion__center_id	20
biospecimen_shipment_portion__is_ffpe	no
biospecimen_shipment_portion__plate_id	a17j
biospecimen_shipment_portion__portion_number	21
biospecimen_shipment_portion__portion_sequence	2
biospecimen_shipment_portion__shipment_portion_bcr_aliquot_barcode	tcga-ew-a1iz-01a-21-a17j-20
biospecimen_shipment_portion__shipment_portion_day_of_shipment	2
biospecimen_shipment_portion__shipment_portion_month_of_shipment	8
biospecimen_shipment_portion__shipment_portion_year_of_shipment	2011
biospecimen_slide__bcr_patient_uuid	c0f88fc5-56b0-4255-bbd1-9a21ced8b37b
biospecimen_slide__bcr_sample_barcode	tcga-ew-a1iz-01a
biospecimen_slide__bcr_slide_barcode	tcga-ew-a1iz-01a-01-tsa
biospecimen_slide__bcr_slide_uuid	a52af132-ed54-40a0-931b-913928cf057f
biospecimen_slide__image_file_name	tcga-ew-a1iz-01a-01-tsa.a52af132-ed54-40a0-931b-913928cf057f.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	0
biospecimen_slide__percent_monocyte_infiltration	0
biospecimen_slide__percent_necrosis	0
biospecimen_slide__percent_neutrophil_infiltration	0
biospecimen_slide__percent_normal_cells	0
biospecimen_slide__percent_stromal_cells	10
biospecimen_slide__percent_tumor_cells	90
biospecimen_slide__percent_tumor_nuclei	85
biospecimen_slide__section_location	top
biospecimen_tumor_sample__bcr_patient_barcode	tcga-ew-a1iz
biospecimen_tumor_sample__bcr_patient_uuid	c0f88fc5-56b0-4255-bbd1-9a21ced8b37b
clinical_drug__bcr_drug_barcode	tcga-ew-a1iz-d21547
clinical_drug__bcr_drug_uuid	748a06a9-bbdf-473e-a546-c7831fad5211
clinical_drug__bcr_patient_barcode	tcga-ew-a1iz
clinical_drug__bcr_patient_uuid	c0f88fc5-56b0-4255-bbd1-9a21ced8b37b
clinical_drug__form_completion_date	2012-2-15
clinical_drug__pharma_adjuvant_cycles_count	6
clinical_drug__pharmaceutical_therapy_drug_name	taxotere
clinical_drug__pharmaceutical_therapy_type	chemotherapy
clinical_drug__pharmaceutical_tx_dose_units	mg
clinical_drug__pharmaceutical_tx_ended_days_to	176
clinical_drug__pharmaceutical_tx_ongoing_indicator	no
clinical_drug__pharmaceutical_tx_started_days_to	70
clinical_drug__pharmaceutical_tx_total_dose_units	mg
clinical_drug__prescribed_dose	139
clinical_drug__regimen_number	tac
clinical_drug__route_of_administration	iv
clinical_drug__therapy_regimen	adjuvant
clinical_drug__total_dose	834
clinical_follow_up__bcr_followup_barcode	tcga-ew-a1iz-f21543
clinical_follow_up__bcr_followup_uuid	78fcd753-17e1-4043-8a55-b3db082e3a80
clinical_follow_up__bcr_patient_barcode	tcga-ew-a1iz
clinical_follow_up__bcr_patient_uuid	c0f88fc5-56b0-4255-bbd1-9a21ced8b37b
clinical_follow_up__followup_reason	scheduled follow-up submission
clinical_follow_up__form_completion_date	2012-2-6
clinical_follow_up__last_contact_days_to	554
clinical_follow_up__new_tumor_event_dx_indicator	no
clinical_follow_up__radiation_treatment_adjuvant	yes
clinical_follow_up__targeted_molecular_therapy	yes
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_patient__age_at_diagnosis	53
clinical_patient__ajcc_metastasis_pathologic_pm	mx
clinical_patient__ajcc_nodes_pathologic_pn	n2a
clinical_patient__ajcc_pathologic_tumor_stage	stage iiia
clinical_patient__ajcc_staging_edition	7th
clinical_patient__ajcc_tumor_pathologic_pt	t2
clinical_patient__anatomic_neoplasm_subdivision	left lower outer quadrant
clinical_patient__axillary_staging_method	axillary lymph node dissection alone
clinical_patient__bcr_patient_barcode	tcga-ew-a1iz
clinical_patient__bcr_patient_uuid	c0f88fc5-56b0-4255-bbd1-9a21ced8b37b
clinical_patient__birth_days_to	-19706
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_ihc_score	3+
clinical_patient__er_positivity_scale_used	3 point scale
clinical_patient__er_status_by_ihc	positive
clinical_patient__er_status_ihc_Percent_Positive	90-99%
clinical_patient__ethnicity	not hispanic or latino
clinical_patient__form_completion_date	2011-5-11
clinical_patient__gender	female
clinical_patient__her2_ihc_percent_positive	<10%
clinical_patient__her2_status_by_ihc	negative
clinical_patient__histological_type	infiltrating ductal carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8500/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2010
clinical_patient__last_contact_days_to	260
clinical_patient__lymph_nodes_examined	yes
clinical_patient__lymph_nodes_examined_count	14
clinical_patient__lymph_nodes_examined_he_count	5
clinical_patient__margin_status	negative
clinical_patient__menopause_status	post (prior bilateral ovariectomy or >12 mo since lmp with no prior hysterectomy)
clinical_patient__metastatic_tumor_indicator	no
clinical_patient__method_initial_path_dx	other method, specify:
clinical_patient__method_initial_path_dx_other	stereotactic biopsy
clinical_patient__micromet_detection_by_ihc	no
clinical_patient__patient_id	a1iz
clinical_patient__pr_positivity_ihc_intensity_score	3+
clinical_patient__pr_positivity_scale_used	3 point scale
clinical_patient__pr_status_by_ihc	positive
clinical_patient__pr_status_ihc_percent_positive	90-99%
clinical_patient__prospective_collection	no
clinical_patient__race	white
clinical_patient__retrospective_collection	yes
clinical_patient__surgical_procedure_first	modified radical mastectomy
clinical_patient__tissue_source_site	ew
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
clinical_radiation__bcr_patient_barcode	tcga-ew-a1iz
clinical_radiation__bcr_patient_uuid	c0f88fc5-56b0-4255-bbd1-9a21ced8b37b
clinical_radiation__bcr_radiation_barcode	tcga-ew-a1iz-r21549
clinical_radiation__bcr_radiation_uuid	fa7e93f3-a23c-4264-83bf-68b207e736b2
clinical_radiation__course_number	1
clinical_radiation__form_completion_date	2012-2-15
clinical_radiation__radiation_adjuvant_fractions_total	8
clinical_radiation__radiation_adjuvant_units	cgy
clinical_radiation__radiation_therapy_ended_days_to	261
clinical_radiation__radiation_therapy_ongoing_indicator	no
clinical_radiation__radiation_therapy_site	local recurrence
clinical_radiation__radiation_therapy_started_days_to	197
clinical_radiation__radiation_therapy_type	external beam
clinical_radiation__radiation_total_dose	6,100
clinical_radiation__therapy_regimen	adjuvant
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-EW-A1IZ-01A-11D-A188-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-EW-A1IZ-01A-11D-A188-09.bed.meta
manually_curated__id	tcga-ew-a1iz-01a-11d-a188-09
manually_curated__md5sum	da972fede8e7c78d2608680d8e562c29
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	18db4143-48cc-424c-8d23-46cf23056528
manually_curated__tumor_tag	brca
